HIGHFDA DEVICE

MicroPort Recalls HIPTURN Fem Head Trial Device Over FDA Violation

MicroPort Orthopedics recalled 91 units of the HIPTURN Fem Head Trial 36mm Reusable device on December 19, 2025. The recall follows the lack of FDA premarket authorization for distribution in the United States. The affected devices were distributed across multiple states and several countries, posing a potential health risk to patients and healthcare providers.

Official notice
MicroPort OrthopedicsHealth & Personal CareMedical DevicesLot Code: Part Number HTHT0036all lotsno future lots planned. Primary DI Number 00192629320130. Secondary Device ID M684HTHT00361

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 19, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 19, 2025
Hazard Level
HIGH
Brand
MicroPort Orthopedics
Category
Health & Personal Care
Sold At
Multiple Retailers
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
MicroPort Orthopedics
Product type
Surgical Device
Model numbers
Lot Code: Part Number HTHT0036, all lots, no future lots planned. Primary DI Number 00192629320130. Secondary Device ID M684HTHT00361
Sold at
Multiple Retailers

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 19, 2025

  2. Reported by FDA DEVICE

    January 28, 2026

  3. RecallRadar source check

    February 4, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Due to products not having FDA Premarket authorization to be distributed within the United States.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact MicroPort Orthopedics Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

The HIPTURN Fem Head Trial device is used in orthopedic procedures to assist in surgical planning and execution. Healthcare providers utilize such devices to ensure precision during surgeries.

Why This Is Dangerous

The lack of FDA premarket authorization raises serious concerns about the safety and efficacy of the device. Without proper evaluation, there is no assurance of its performance or potential risks to patients.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

This recall places a significant burden on healthcare providers who must stop using the device, potentially disrupting surgical schedules and leading to delays in treatment.

Practical Guidance

How to identify if yours is affected

  1. Check the model number on your device to see if it is HTHT0036.
  2. Verify the lot code against the recall information provided by MicroPort Orthopedics.
  3. Contact your distributor for confirmation on your device's status.

Where to find product info

The lot codes and model number can typically be found on the packaging or the device itself.

What timeline to expect

Expect a processing time of 4-6 weeks for any refund or replacement from MicroPort Orthopedics.

If the manufacturer is unresponsive

  • Document all communications with MicroPort Orthopedics.
  • Reach out to the FDA for additional guidance or to file a complaint.

How to prevent similar issues

  • Always ensure medical devices are FDA-approved before use.
  • Consult with healthcare providers about the safety evaluations of surgical tools.
  • Stay informed about recalls in the medical device industry.

Documentation advice

Keep records of your purchase, any communication from the manufacturer, and details regarding the device for your records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recalled product is the HIPTURN Fem Head Trial 36mm Reusable, model number HTHT0036. It was distributed to various states including Texas, California, and Wisconsin, as well as internationally to countries like Belgium and Japan.

Key Facts

  • Distributed to multiple U.S. states and countries
  • No reported incidents or injuries
  • Stop using the device immediately
  • Contact MicroPort for instructions

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot Code: Part Number HTHT0036
all lots
no future lots planned. Primary DI Number 00192629320130. Secondary Device ID M684HTHT00361
Report Date
January 28, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more